Algeria's Saidal group signed on Tuesday a partnership agreement with the Jordan-based Arab Company for Drug Industries and Medical Appliances (ACDIMA) to carry out bio-equivalence studies in Algeria, the official Algerian news agency APS reported.
According to the agreement, the two sides will create a joint venture to carry out "compliance studies of generic drugs with the original ones." The joint-venture, in which Saidal will hold a 60-percent ownership and Acdima 40 percent, will be "squarely independent" from Saidal for transparency reasons, the Algerian firm said.
Generic manufacturers in Algeria currently buy their pharmaceutical records in order to use them in the domestic drug production.
ACDIMA is a pan-Arab shareholding company established by a resolution from the Arab Economic Unity Council in 1976. It aims to build relations with multinational bodies to assist in setting up and participating in projects in the Arab World.
Saisal is an Algerian company founded by the government in 1982.
GMT 19:07 2018 Friday ,14 December
Lebanese PM flags up Saudi investment potential, financial tiesGMT 21:16 2018 Thursday ,13 December
Egypt, Algeria sign MoU to increase trade exchangeGMT 12:33 2018 Sunday ,09 December
Egypt's decision to adjust customs' duties on luxury goods to benefit economyGMT 21:03 2018 Wednesday ,05 December
Bahrain's economic delegation concludes successful India visitGMT 10:58 2018 Sunday ,02 December
Egypt’s total public investments record EGP 72 bln in Q1GMT 14:23 2018 Friday ,30 November
Saudi Arabia pledges $50 million to UNRWAGMT 20:20 2018 Thursday ,29 November
Japan funds project to enhance water quality project in Palestinian townGMT 09:50 2018 Wednesday ,28 November
Egypt, Saudi Arabia to strengthen economic ties in coming phaseMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor